Ma. Caligo et al., NM23 GENE-EXPRESSION IN HUMAN BREAST CARCINOMAS - LOSS OF CORRELATIONWITH CELL-PROLIFERATION IN THE ADVANCED PHASE OF TUMOR PROGRESSION, International journal of cancer, 74(1), 1997, pp. 102-111
NM23 is a protein associated with tumor progression, expressed in all
tissues and in human tumors. Reduced expression of NM23.H1 is related
to high incidence of lymph node and distant metastasis or to poor prog
nosis of the patient in several human malignant tumors. In this study
we analyze NM23 expression in non-neoplastic mammary tissues surroundi
ng the tumoral lesions, in human mammary carcinomas and in lymph node
metastasis. Our analysis shows that NM23.H1 expression is lower in the
mammary cells surrounding the tumor than in the tumor itself. In the
primary tumors we observed a negative trend between degree of local in
vasion and level of NM23.H1 expression. A further decrease of NM23.H1
was detected in the invasive tumors that metastasized to axillary lymp
h nodes and in the metastasis. NM23.H2 was always more highly expresse
d than NM23.H1, and reduced expression of NM23.H1 but not NM23.H2 was
concordant with the presence of lymph node metastasis or local invasiv
eness of the primary tumor. A positive correlation between NM23.H1 mRN
A content and cell growth rate of breast tumor cells has been confirme
d. However, this trend was not maintained in cancer cells from tumors
that metastasized to axillary lymph nodes and in metastatic cells; in
these 2 situations the NM23.H1 mRNA content varied without any relatio
nship to the proliferative rate of the cells. In addition, in comparis
on with the initial tumor, the metastatic cell population showed a str
ong decrease of NM23.H1 expression and increased proliferative activit
y. (C) 1997 Willy-Liss, Inc,.